Personalized Therapy of Patients Suffering From Rare Genodermatoses

Status Recruiting

Clinical Trial Summary

Rare skin diseases are generally defined as serious life-threatening, progressive chronic diseases of the skin that occur extremely rarely (i.e., 5 in 10,000 people are affected). More than 80% are hereditary. In most cases, late diagnosis and the lack of therapeutic strategies also contribute to severe disease progression. Therefore, new therapeutic options are urgently needed and with them knowledge of the underlying mechanisms of disease development. The aim of this project is to better understand disease mechanisms and to identify new pathways and drug targets that will improve patient care or therapy. In order to investigate the mechanisms of disease development, it is necessary to isolate biological material, i.e. blood and affected skin tissue from patients. For this purpose, adults 18 years of age and older with a congenital rare skin disease are included. We take blood and (lesional) skin biopsies from patients to perform immunoprofiling, as well as cell biological studies with the patient's cells. The risk for the patients is low, as only peripheral blood and skin biopsies are taken. Potential risks include bruising and pain as well as infection, postoperative bleeding, wound infection or delayed wound healing, pain, and scarring. The samples are pseudonymized and stored with the pseudonym only. Cells and skin samples are only preserved with the prior consent of the patient.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Rare Diseases

Clinical Trial Details

NCT number	NCT05680974
Study type	Observational
Source	Johannes Kepler University of Linz
Contact	Monika Ettinger, MD PhD
Phone	+43 5 7680 83
Email	monika.ettinger@kepleruniklinikum.at
Status	Recruiting
Phase
Start date	March 18, 2022
Completion date	December 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05794217` - A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives
Completed	`NCT03680365` - Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families
Completed	`NCT03290469` - NICUSeq: A Trial to Evaluate the Clinical Utility of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Acute Care Neonates and Infants	N/A
Not yet recruiting	`NCT05955794` - Vocal Pattern Assessment as a New Key to Identifying Rare Syndromes	N/A
Recruiting	`NCT04429750` - Intact Cord Resuscitation in CDH	N/A
Not yet recruiting	`NCT04152876` - Functional Genomics of Rare Genetic Diseases: Realization of Innovative Tools With High Diagnostic Power
Recruiting	`NCT03683966` - MigALastat Therapy Adherence Among FABRY Patients: A Prospective Multicentral Observational Study
Not yet recruiting	`NCT04319796` - European Registry on Rare Neurological Diseases
Completed	`NCT02736565` - Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma	Phase 1
Completed	`NCT05070988` - Oral Health Related Quality of Life of Patients With Rare Diseases: a Qualitative Approach
Completed	`NCT03563677` - Dual Guidance Structure for Evaluation of Patients With Unclear Diagnosis in Centers for Rare Diseases	N/A
Recruiting	`NCT05499091` - Functional Study to Indentify Genetic Etiology of Rare Diseases - ORIGIN	N/A
Completed	`NCT03954652` - Whole Genome Trio Sequencing as a Standard Routine Test in Patients With Rare Diseases - "GENOME FIRST APPROACH"	N/A
Recruiting	`NCT05703893` - Investigation of the Neurovegetative Pattern in Patients With Thoracic Aortic Aneurysms (TAA)
Enrolling by invitation	`NCT04703179` - Rare and Undiagnosed Disease Research Biorepository
Recruiting	`NCT04024774` - Diagnostic Research in Patients With Rare Diseases -Solving the Unsolved Rare Diseases
Recruiting	`NCT06343558` - Gait and Balance Impairment in Rare and Very Rare Neurological Diseases
Enrolling by invitation	`NCT04654000` - Rheopheresis as Adjuvant Treatment of Calciphylaxis	N/A
Recruiting	`NCT04651439` - Severe Bullous Drug Eruption and Filgrastim	Phase 2/Phase 3
Recruiting	`NCT03491280` - Diagnostic Research in Patients With Rare Diseases - Solving the Unsolved Rare Diseases